Jeffrey A. Jones, MD

Chief of Urology – M.E. De Bakey VA Medical Center
Professor of Urology, Baylor College of Medicine
Scott Dept of Urology
7200 Cambridge Ave Suite Alo. 133
Houston, TX 77030, USA

 

Biography

EDUCATION

• B. A. Trinity University, 715 Stadium Dr. San Antonio, Texas 78212 Double Major- Biology, Psychology (May, 1981)
• M. D. Baylor College of Medicine, One Baylor Plaza Houston, Texas 77030 (November, 1984)
• M.S. University of Texas Medical Branch, 301 University Blvd. Galveston, TX 77555-0132, Preventive Medicine & Community Health, (December, 1998)

APPOINTMENTS

• Chief of Urology ME DeBakey Veterans Administration Medical Center Houston, TX (July 2013-P)
• Professor- Baylor College of Medicine Urology Department/Center for Space Medicine (2013-P)
• Clinical Professor- University of Texas Medical Branch (2006-P)
• Captain – United States Naval Reserves Medical Corps- (1989-P)
• Fleet Logistics Support Wing Surgeon (December 2014-P)
• Federal Aviation Administration designated Aviation Medical Examiner #80033 (1997-P)
• Previous NASA/JSC Medical Operations Assignments/Duties
• Medical Operations Physician/ Flight Surgeon-National Aeronautics and Space Administration/Johnson Space Center- (1998-2010)
• Orion (CEV) Vehicle Integration Office Crew Health Liaison (February 2008-2010)
• Lead for Exploration Medical Operations- (February 2005-2010)
• CEV(Orion) Occupant Protection Team member
• Medical Element Lead- EVA Physiological Systems Project- (March 2006-2010)
• Crew Health Representative- Lunar Architecture Team – Habitat Element (August 2007-2010)
• Crew Health Representative- Mars Architecture Team (October 2007-2010)
• Member of Lunar Exploration Analysis Group (2005-2010)
• Member of Mars Exploration and Planning Group (2005-2010)
• Lunar Surface Systems Team- Medical and Life Sciences Rep (2008-2009)
• Crew Exploration Vehicle Systems Manager for Crew Health Interfaces- (October 2006-January 2007)
• Chairman, Exploration Crew Health Integration Team- (2005-2007)

Research Interest

His research interest includes Urology

Scientific Activities

MEMBERSHIPS

• CEV (Orion) Occupant Protection Team member
• Member of Lunar Exploration Analysis Group (2005-2010)
• Member of Mars Exploration and Planning Group (2005-2010)
• Member of the NASA/JSC CPHS/ Institutional Review Board (1998-2004)
• Executive Council-Space Medicine Association of AsMA-(2004-2007)
• Merchandising Committee- Associate Fellows of AsMA-(2006)
• Vice President Society of NASA Flight Surgeons –(2007-2008)
• President Society of NASA Flight Surgeons- (2008-2009)
• Membership Committee- AsMA (2008-2010)
• Awards Committee- AsMA Fellows Organization (2011-P)

Publications

1. Fehir K, Jones J, Noon G, Yawn D. Preoperative autologous plateletpheresis and plasmapheresis in patients undergoing cardiopulmonary bypass. J Clin Apher. 1990; 5(2): 91-96.
2. Don S, Kopecky KK, Leapman SB, et al. Duplex sonography in renal allografts: causes of elevated resistive index. Syllabus of the RSNA 88 Meeting (read before the 76th scientific assembly Radiologic Society of North America, Chicago, IL 1988)
3. Hardacre J, Goulet RH, Einhorn LH, Loehrer PJ, Jones JA, Donohue JP, Madura JA. Hepatic resection for metastatic testicular cancer. (read before Amer Surg Assn Meeting, Wash DC, 1990).
4. Jones JA, Don S, Kopecky KK, et al. Utilization of doppler duplex sonography in evaluating post transplant renal allograft dysfunction. J Urol. 1990; 143(4): 225-228.
5. Thornhill JA, Donohue JP, Jones JA, Rowland RG, Foster R, Bihrle R. Renal considerations during the surgical management of testis cancer. (1990 AUA Meeting, New Orleans)
6. Jones JA, Lingeman JE, Steidle CP. ESWL vs PCNL in the management of caliceal diverticula. Adv Biliary & Urinary SWL Syllabus, 1990.
7. Lingeman JE, Jones JA, Steidle CP. Extracorporeal shock wave lithotripsy vs percutaneous management of caliceal diverticula. J Endourology J Urol. 1990 334, 145: 296A (presented at the NCAUA meeting Oct 1990, Colorado Springs, CO and 1991 AUA Meeting, Toronto, Canada)
8. Jones JA, Regan JS, Kriauciunas TD, et al. A role for PDGF in the genesis of prostatic disease. Syllabus of the NCSAUA 90 Meeting (presented at the NCAUA Oct,1990, Colorado Springs, CO).
9. Hirsch KS, Jones JA, Regan JR, et al. Identification and characterization of the PDGF receptors in cells derived from human benign prostatic hyperplasia. J Cellular Biochemistry 15B Suppl.
105; D121, 1991. (Presented at the UCLA/Keystone Symposium on Molecular and Cellular Biology: Growth Factor and Signal Transduction & Gene Regulation and Signaling in Endocrine Systems. 1/24-30/1991).
10. Kriauciunas T, Hirsch KS, Jones JA, et al. PDGF-Induced proliferation of cells derived from human benign prostatic hyperplasia. J Cellular Biochemistry 15B Suppl. 107; D127, 1991. (Presented at the UCLA/Keystone Symposium 1991).
11. Jones JA, Haggard KL, Angermeier PA, Foster RS. Transrectal prostatic biopsy: improved sensitivity with FNA and Biopty core biopsy techniques. Syllabus of the North Central Section, American Urologic Association 1991 Meeting (presented NCAUA 1991 meeting, Scottsdale, AZ
12. Angermeier P, Jones J, Haggard K, Foster R, Eble J. Transrectal prostatic biopsy: improvement in sensitivity with combined fine needle aspiration and Biopty@ core biopsy techniques. Modern Pathology. 1991; 4:43A. (presented U.S./Canadian Division International Academy of Pathology, 1991, Chicago, IL)
13. Lingeman JL, Jones JA, Steidle CP. PCNL more effective than ESWL in treating caliceal diverticula. Urology Meeting Reporter 1991; 2.
14. Jones JA, Gleason PG, Regan JS, et al. PDGF: An etiologic factor in the development of benign prostatic hyperplasia. J Urol. 145:330A; 470, 1991.
15. Jones JA, Mitchell ME, Rink RC. Improved results utilizing a modified bladder neck reconstruction. J Urol. 143(4): 200A; 46, 1990. (Presented at 90 AUA, New Orleans)
16. Eble JN, Jones J, Regan J, Vlahos C, Gehlert D, Falcone J, ne N, Hirsch K. Characterization and activity of Platelet-derived growth factor receptors in cell cultures from hyperplastic human prostate. Modern Pathology. 4:45A, 1991. (presented U.S/Canadian Division International Academy of Pathology, 1991, Chicago, IL)
17. Gleason PG, Jones JA, Regan JR, et al. Platelet-Derived Growth Factor(PDGF) and inflammation: possible etiologic mechanisms. Syllabus of NCS AUA 91 Meeting (NCS AUA 1991, Phoenix, AZ)
18. Jones JA, Vlahos CJ, Stamm N, Hirsch, KS. Effects of suramin on growth factor-induced signal transduction pathways in human prostate carcinoma cells. (J Cell Biochem Suppl. 16D p106 3/92 Keystone Symposium on Breast and Prostate Cancer, 1992
19. Jones JA, Lingeman JL, Steidle CP. Controversy in the management of pyelocaliceal diverticula, ESWL vs. PCNL. By invitation: Clinical Digest Series: Urology/Nephrology Digest:17-18, 1992.
20. Jones JA, Gleason PE, Salvas DS, Eble JN, Ellis L, Fouts R, Lamph WW, Hirsch KS, Vlahos CJ. A model of inflammation as an etiologic agent in the development of prostatic hyperplasia: The roles of PDGF, interleukins and androgens. (presented at the Society for Basic Urologic Research annual meeting Washington, D.C. 5/92
21. Jones JA, Gleason PE, Salvas DS, et al. A model of inflammation as an etiologic development of benign prostatic hyperplasia: The roles of biology of prostatic growth. Bethesda, Maryland. 9/92
22. Jones J, Bell D, Salvas D, et al. Extragonadal germ cell tumors represent a separate clinical entity. (Presented at the Western Section of the AUA Meeting. Maui, Hawaii. 10/92)
23. Jones J, Bell D, Salvas D, et al. Profiles of patients with testicular maldescent who develop germ cell malignancies. (Presented at the Western Section of the AUA Meeting. Maui, Hawaii. 10/92)
24. Jones JA, Vlahos C, Salvas D, et al. Indiana University/Eli Lilly and Company, Indianapolis, IN: Dysregulated signal transduction in prostate carcinoma. 6th Annual Conference on Prostate Cancer Prouts Neck, Maine10/92
25. Jones JA, Gleason PE, Salvas D, Fouts R, Bumol T, Hirsch KS, Vlahos CJ. Inflammation as a mediator in the develpoment of BPH: differences between normal and hyperplastic prostatic stromal cells. Proceedings of 40th annual James C. Kimbrough Meeting. (Presented in Seattle, Washington. 11/92)
26. deRiese WTW, Walker EB, deRiese C, et al. Predictive value of proliferative parameters measured by flow cytometry in early stage nonseminomatous germ cell tumor. J Urol Vol. 149(4): 453A; 962. (Presented at AUA 88th Annual Meeting, San Antonio, TX 05/15-30-93)
27. Bennett J, Salvas D, Jones J, et al. Outcome of patients with testicular maldescent who develop germ cell neoplasms. J Urol. 2009; 149(4): 226A; 50 (Presented at AUA 88th Annual Meeting, San Antonio, TX 5/15/94)
28. Akhter S, Bunn P, Illner H, et al. Continent intestinal reservoir for dialysis in chronic renal failure. Presented at American College of Surgeons 79th Clinical Congress, San Francisco, CA. 10/14/93
29. Jones J, Avant L, Ortiz V, et al. The use of the dorsal venous ligation in radical prostatectomy and other urologic procedures. Published 41st Annual James C. Kimbrough Urological Seminar, San Diego, CA 10/29/93
30. Avant L, Beck H, Straub M, Gilliland J, Jones J. The Use of dorsal venous ligation with anterior urethropexy in radical retropubic prostatectomy. Fourth International Prostate Cancer Update Syllabus. 01/27-30/94
31. Jimenez MA, Goulet RJ, Loehrer PJ, Jones JA, Einhorn LH, Donohue JP. Hepatic resection of metastatic testicular carcinoma. (Presented at Society of Surgical Oncology, Los Angeles, CA) 1993.
32. Bennett R, Salvas D, Jones J, et al. Outcome of patients with testicular maldescent who develop germ cell neoplasms. J of Urology. Vol 149 4: 226A 50. , 1993. (Presented at AUA Eighty-Eighth Annual Meeting, San Antonio, Tx 05/15-0/93).
33. deRiese WTW, Walker EB, deRiese C, et al. Predictive value of proliferative parameters measured by flow cytometry in early stage nonseminomatous germ cell tumor (NSGCT). J Urology. Vol 149 4: 453A
34. Jones J, Straub M, Vordermark J, Stalcup O, Ortiz V, Avant L. Improvements in continence using dorsal venous ligation with anterior urethropexy in radical retropubic prostatectomy. J Cell Biochem. 253, Y510. 02/26/94-04/17/94. Presented at Keystone Symposia, Breast & Prostate Cancer II, Lake Tahoe, CA. 03/14-20/94
35. Jones J, Straub M, Kaefer M, et al. Combination modality treatment strategy for extragondal germ cell umors. J of Urology. (suppl.) Vol 151 5: 244A 67, 1994. Presented at AUA Eighty-Ninth Annual Meeting, San Francisco, CA. 05/14-19/94
36. Akhter S, Greene S, Illner H, Jones J, Powell D, Shires GT. A study of dialysis capabilities of various segments of intestine for use in chronic renal failure. J of Urology. 1994; 151(5): 385A. Presented at AUA Eighty-Ninth Annual Meeting, San Francisco, CA. 05/14-19/94
37. Avant L, Beck J, Straub M, Gilliland J, Jones J. Results in the use of dorsal venous ligation with anterior urethropexy in radical retropubic prostatectomy. Published in 73rd Annual Meeting of South Central Section of the American Urological Association, Inc. Bulletin, Vancouver, B.C. 08/27-31/94
38. Jones J, Chen L, Straub M, et al. Conjugation of selenium to a monoclonal prostate tumor antibody, 7E11: Superoxide generation, Elisa and in vitro cytotoxicity. 1996 Keystone Symposium Journal on Breast and Prostate Cancer Basic Mechanisms, Taos, NM 2/2/96.
39. Jones J, Chen L, Straub M, et al. Selenium conjugate induced prostate cancer cell cytotoxicity. Proceedings of the 1996 American Assoc. for Cancer Research Meeting, 1996; 37: 471.
40. Spallholz Julian E, Chen, Lugen, Reid Ted, Jones, Jeff, Straub, Mike, Morrow, John, Butterick, Chuck: Covalent free radical chemistry of selenium immunoconjugates andtheir potentially useful pharmaceutical applications. Presented to The Sixth International Symposium on Selenium in Biology and Medicine 1996.
41. Jones J, Stanford M. Impact of space radiation on an exploratory class mission to mars. Proceedings of the Twelvth Man in Space Symposium. Wash. D.C. 1997.
42. Hilliard P, Jones J, Pietrzyk R, Whitson P. Musculoskeletal Issues For Long Duration Mission: Muscle mass preservation, renal stone risk factors, countermeasures, and contingency treatment planning. Proceedings of the Twelfth Man in Space Symposium. Washington DC 1997
43. Bishop S, Wood J, Jones J. Psychological Issues and Crew Selection for A Mars Mission: Maximizing the Mix for the Long Haul. Proceedings of the Twelfth Man in Space Symposium. Wash. DC 1997
44. Bishop S, Hilliard P, D aunno D, Harris B, Jones J, Rossum A, Stanford M. Bio-behavioral Life Support Issues for Living and Working in Space. Program: International Conference on Life Support and Biosphere Science. Lake Buena Vista, FL, 1998.
45. Jones JA, Riggs PK, Stanford M, et al. Reduction in space radiation-induced bioeffects leading to carcinogenesis with a chemoprevention strategy. Aerospace Medical Assoc. Annual Meeting Syllabus Seattle, WA, 98.
46. Hart SA, Jones JA, Effenhauser R, Jennings R, Davis J. Cervical spinal injury in pilots of high performance aircraft. Aerospace Medical Assoc. Annual Meeting Syllabus Seattle, WA, 98.
47. Jones JA, Riggs PK, Stanford M, et al. Mammalian cells treated with chemoprevention agents show alterations in bioeffects from space radiation. American Institute for Aeronautics and Astronautics Technical Symposium, Houston, TX, 1998.
48. Jones JA, Stanford M. Radiation and surface operational discussion. Special Plenary Panel on Life Sciences Issues in Mars Exploration, Founding Convention of the Mars Society Program Book. (Presented to the Mars Society Convention, Univ. of Colorado, Boulder, CO, August 13-16, 1998).
49. Johnston SL, Jones JA, Ross CE, Cerimele CJ, Fox JL. NASA international space station crew return vehicle seat and cockpit configuration and design challenges. Aerospace Medical Association Annual Meeting Bulletin, Detroit, MI, 1999; 49: 17-20.
50. Jones JA, Johnston SL, Campbell M, et al. Endoscopic Surgery and Telemedicine In Zero Gravity, Contingency Procedures for Exploratory Class Missions; Telemedicine during Lunar Mars Life Support Test Program Phase III, American Institute of Aeronautics and Astronautics Annual Technical Symposium Bulletin. Houston, TX 28, 1999; 35.
51. Jones JA, Shepherd B, Greenisen M, et al. Joint countermeasures and monitoring integration plan for international space station crews. Aerospace Medical Association Annual Meeting Bulletin. Houston, TX, 14-18, 2000.
52. Jones JA, Johnston S, Campbell M, et al. Telemedicine and endoscopic surgery contingency Procedures for exploratory class missions: Phase III lunar mars life support test program and KC-135 zero-gravity aircraft and Mars analogue site test platforms. Aerospace Medical Association Annual Meeting Bulletin, Houston, TX, 14-18, 2000.
53. Jones JA, McGinnis P, Gray G, et al. The Haughton crater on Devon island inside the arctic circle provide a suitable analog site for developing operational strategies for Mars surface operations. Aerospace Medical Association Annual Meeting Bulletin, Houston, TX, 14-18, 2000.
54. Jones JA, Cucinotta F, Zapp N, Badhwar G, Johnson S, Weyland M, Clarke M, Haralson R, Petrov V, Shurshakov S. Joint radiation monitoring integrated plan for ISS, means to enforce the ALARA principle and reduce effects on human performance. Aerospace Medical Association Annual Meeting Bulletin, Houston, TX , 14-18, 2000.
55. Jones JA, McGinnis P, Simmons S, et al. Diagnostics and imaging via telemedicine on Devon Island as a Mars analog. Aerospace Medical Association Annual Meeting Bulletin, Reno, NV, 6-10, 2001.
56. Jones JA, Cucinotta F, Zapp N, et al. Radiation exposures and operational constraints anticipated for long duration flights on the international space station. Aerospace Medical Association Annual Meeting Bulletin, Reno, NV, 6-10, 2001.
57. Butler DJ, Simmons SC, Guess T, Effenhauser R, Jones J, McGinnis P. The NASA Haughton Mars Project: Validation of Medical Technologies and Operations on Devon Island. American Telemedicine Association Annual Meeting, Fort Walton Beach, Florida; 2001.
58. Jones JA, Scheurger A, McAvin, et al. Technologies for microbial detection to support both vehicle/habitat medical monitoring and planetary astrobiology during human surface exploration of Mars. Aerospace Medicine Association 73rd Annual Scientific Meeting Montreal, Quebec, Canada; 2002.
59. Jones JA, Guilliams M, Shepherd B. Countermeasures to maintain human systems and enhance performance during long duration spaceflight microgravity: refinements from lessons learned during NASA/Mir. Aerospace Medicine Association 73rd Annual Scientific Meeting Montreal, Quebec, Canada; 2002.
60. Crucian BE, Jones JA, Effenhauser E, Lee P, Sams C. Alterations in fine leukocyte subsetduring simulated Mars exploration missions at Haughton Crater. Bulletin of Aerospace Medicine Association 73rd Annual Scientific Meeting Montreal, Quebec, Canada; 2002.
61. Larios-Sanz M, Kourentzi K, Warmflash D, Jones JA, Willson RC, Pierson DL, Fox, GE. 16S rRNA Beacons for Bacterial Monitoring in Craft and Habitat Modules in Human Space Missions. . Bulletin of Aerospace Medicine Association 73rd Annual Scientific Meeting Montreal, Quebec, Canada 8, 2002.
62. Warmflash D, Larios-Sanz M, Jones JA, Fox GE, Mckay DA. Assessing the biohazard potential of putative martian organisms for exploration class human space missions. Bulletin of Aerospace Medicine Association 73rd Annual Scientific Meeting Montreal, Ontario, Canada 8, 2002.
63. Holland DA, Muccio JD, Jones JA. A systems examination of key issues for long duration Space flight to Mars with emphasis on theoretical bone demineralization profiles for various orbital trajectories, and some further comments on countermeasures under investigation. Aerospace Medicine Symposium Sydney, Australia; 2002.
64. Melton S, Jones J, Hamilton D, Meir J, Hurst V, Sargsyan A. Activation and checkout of the Human Research Facility (HRF) Ultrasound for Medical Contingencies on the International Space Station (ISS) Bulletin of Aerospace Medicine Association 74th Annual Scientific Meeting San Antonio, TX 5, 2003.
65. Sargasyan A, Hamilton D, Jones J, Martin D, Whitson P, Melton S. Clinical capability enhancement with diagnostic ultrasound imaging aboard the International Space Station (ISS) Bulletin of Aerospace Medicine Association 74th Annual Scientific Meeting San Antonio, TX 7, 2003.
66. Jones J, Sargasyan A, Whitson P, Melton S, Martin D, Hamilton D. Development of imaging protocols for in-flight screening of genitourinary diseases on the International Space Station (ISS) Bulletin of Aerospace Medicine Association 74th Annual Scientific Meeting San Antonio, TX 7, 2003.
67. Crucian B, Lee P, Widen R, Jones J, Sams C. ‘Immune System Alterations during Simulated Mars Planetary Exploration at the Haughton Impact Crater (high Canadian arctic): resolution of specific clinical responses vs. mission-associated dysfunction’ Bulletin of the 14th International Academy of Astronautics- Humans in Space Symposium: Living in Space: Scientific, Medical, and Cultural Implications Banff, Alberta, Canada 19, 2003.
68. Lee P, Braham S, Berinstain A, et al. NASA Haughton-Mars Project: EVA and Expeditionary Telemedicine Research in the Canadian High Arctic for Future Human Moon-Mars Exploration Planning Bulletin of the 14th International Academy of Astronautics- Humans in Space Symposium: Living in Space: Scientific, Medical, and Cultural Implications Banff, Alberta, Canada 21, 2003.
69. Sargasyan A, Jones J, Hamilton D, et al. ‘Development of Diagnostic Imaging Capability for the International Space Station (ISS) and Implications for Future Spaceflight’ Bulletin of the 14th International Academy of Astronautics- Humans in Space Symposium: Living in Space: Scientific, Medical, and Cultural Implications Banff, Alberta, Canada 21, 2003.
70. Pietryzk R, Whitson P, Jones J, Sams C. ‘Overview of Renal Stones and Space Flight ‘Bulletin of the 14th International Academy of Astronautics- Humans in Space Symposium: Living in Space: Scientific, Medical, and Cultural Implications Banff, Alberta, Canada 22, 2003.
71. Viegas S, Williams D, Jones JA, Clark J. Space, The Final Frontier….For Hand Overuse Problems. 58th Annual meeting of the American Society for Surgery of the Hand. Chicago, IL, Sept 19, 2003.
72. Petrylak DP, Tangen C, Hussain M, et al. SWOG 99-16: Randomized Phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone(M)/prednisone(p) in men with androgen-independent prostate cancer (AIPCA) ASCO Plenary session, 2004.
73. Crawford ED, Pauler DK, Tangen C, Hussain M, Small E, Jones JA, Taplin ME, Burch PA, Greene G, Lara PN, Jr. and Daniel Petrylak Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): data from Southwest Oncology Group Study S9916. ASCO 2004.
74. Jones JA, Dervay J, Duncan M, et al. Space Flight Diseases and Injuries: Diagnosis and Treatment. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 249: B54 2004.
75. Sams C, Cintron NM, Jones JA, et al. Biomedical Status of Crews on the International Space Station (ISS) to date. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 250: B54 2004.
76. Sargasyan AE, Dulchavsky SA, Jones JA, Hamilton DR, Kirkpatrick A. Development of Imaging Algorithms on ISS for the Diagnosis of Surgical Conditions. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 251: B54 2004.
77. Viegas S, Jones JA, Williams D, Clark J, Strauss S. Hand/Upper Extremity Overuse and Repetitive Injuries in Astronauts. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 252: B54 2004.
78. Warmflash D, Jones JA, Larios-Sanz M, Fox GE, Ciftcioglu N. Evolution and Monitoring of Pathogenic Microorganisms During Long Duration Human Spaceflight. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 253: B55 2004.
79. Campbell M, Johnston SL, Marshburn TH, Kane J, Lugg D, Jones JA. Non-Operative Treatment Options for Appendicitis during Spaceflight. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 254: B55 2004.
80. Campbell M, Jones JA. Surgical Care in Space. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 315: B68 2004.
80. Campbell M, Jones JA. Surgical Care in Space. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 315: B68 2004.
81. Kirkpatrick A, Dawson D, Campbell M, et al. Extraterrestrial hemorrhage control: Terrestrial developments in technique, technology, and philosophy with applicability to traumatic hemorrhage in space. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 316: B68-69 2004.
82. McSwain NE, Jones JA, Pool SL, Doerr HK. Considerations for the Use of Anesthesia On-orbit or immediately post Re-entry. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 317: B69 2004.
83. Broderick TJ, Doarn CR, Merrell RC, Rafiq A, Jones JA, Cagle Y. Evaluation of Computer-based Virtual Reality Simulation on the KC-135. Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 319: B69 2004.
84. Smith K, Louw D, McBeth P, Jones J, Hamilton DR, Kirkpatrick A. Surgical Simulation: An Opportunity to Train for Space Surgery on Earth Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 320: B69 2004.
85. Fielding T, McBeth P, Louw D, Jones J, Hamilton DR, Kirkpatrick A. Technical Requirements for autonomous image guided robotic surgery in space: could HAL do the job? Presented AsMA annual meeting 2004, Aviation, Space and Environmental Medicine, suppl. 75(4) section II, 321: B69-70 2004.
86. Jones JA, Sargsyan AE, Melton SL, Martin DS, Hamilton DR. Imaging Protocols for Genitourinary Conditions on the International Space Station (ISS) J Urol. 171(4) 1964: 518-19, 2004.
87. Pietrzyk RA, Whitson PA, Nelman-Gonzalez MA, Jones JA, Sams CF. Renal Stone Risk during Space Flight Assessment and Countermeasure Validation. USRA/DSLS Bioinvestigators Workshop Abstract Volume (Presented uary 12, 2005) Annual Meeting uary 10-12, 2005 Galveston, TX.
88. Reid MB, Arbogast S, Smith J, Kennedy AR, Jones JA. Antioxidants Oppose Weakness and Fatigue in Skeletal Muscle. USRA/DSLS Bioinvestigators Workshop Abstract Volume (Presented uary 10, 2005) Annual Meeting uary 10-12, 2005 Galveston, TX.
89. Brown II, Jones JA, Bayless D, Karakis S, Karpov L, McKay DS. Novel Concept for LSS Based on Advanced Microalgal Biotechnologies. Habitation Vol 10 (3,4) (Presented Habitation 2006 conference, Orlando, FL, Feb, 2006).
89. Jones JA, Sams C, Leblanc A, et al. Countermeasures for Muscle and Bone Losses on Exploration Missions: “How can we use the ISS to learn what we need to know? ASEM 76 (3) 2005.
90. Jones JA, Connolly J, Bauer P, Smaka T, Campbell M, Hart SF. New Vehicles under design to Open Exploration of the Moon and Beyond: Space Medical Considerations. ASEM 77(3): 2006 p. 284 abstract 279.
91. Polk J, Lee S, Taddeo T, Jones JA. Physiological Considerations for Exploration Missions. ASEM 77(3): 2006 p. 284 abstract 280.
92. Jones JA, Hamilton DR, Scheuring RA. CEV/Lunar Medical Contingency Management and Medical Care Systems. ASEM 77(3): 2006 p. 284 abstract 28.
93. Clark JB, Chandler M, Arnold AA, Johnston S, Jones JA. CLV Crew Survivability and Contingency Systems. ASEM 77(3): 2006 p. 285 abstract 283.
94. Gernhardt M, Welch J, Conkin J, Hagan D, Kuznetz L, Jones JA. Contingency 0-g and Planetary EVA Issues. ASEM 77(3): 2006 p. 285 abstract 284.
95. Chandler M, Polk J, Hart SF, Duncan M, Jones JA. Medical Ground Support Considerations for Crew Exploration Vehicle. ASEM 77(3): 2006 p. 301 abstract 344.
96. Lewis J, Packham N, Mudgett P, Van Baalen M, Jones JA. ECLS and Environmental Monitoring Development for Exploration. ASEM 77(3): 2006 p. 301 abstract 345.
97. Warmflash D, Kerschman R, James J, Khan N, McKay D, Jones J. Lunar Dust and Astronaut Occupational Health. ASEM 77(3) 2006, p.302 abstract 346.
98. Rajulu S, Whitmore M, Cavenall I, Jones JA. Human Factors Interface and Anthropometrics. ASEM 77(3) 2006, p.302 abstract 347.
99. Korth D, Hayes J, Loerch L, Barrratt M, Hagan D, Jones JA. CEV and Lunar Exercise Countermeasure Systems Limitations. ASEM 77(3) 2006, p.302 abstract 348.
100. Sargsyan A, Dulchavsky SA, Jones JA, et al. Abdominal Imaging with Ultrasound on the International Space Station. ASEM 77(3) 2006, p.276 abstract 248.
101. Jones JA, Carlson G, Olavi Kader E, et al. A Preliminary analysis of calcifying particles in the serum and prostates of patients with prostatic inflammation. J Urology. 2006; 175(4): 31.
102. Maliev V, Popov D, Jones JA, R C Casey. Countermeasures for high-dose radiation bioeffect reduction. 17th Annual Space Radiation Health Investigators Workshop and 4th International Conference on Radiation Research Russian Academy of Sciences, Moscow, Russia 5, 2006.
103. Maliev V, Popov D, Jones JA, Casey RC. Mechanism of action for anti- radiation vaccine in reducing the biological impact of high-dose irradiation 36th COSPAR Annual Meeting Bulletin, Beijing, China , 2006.
103.5 Popov, Dmitri, Maliev, Vecheslav, Jones, Jeffrey, Casey, Rachael. Anti-radiation vaccine: Immunologically-based prophylaxis of acute toxic radiation syndromes, associated with long-term space flights . Third International Symposium, Problems in Space Biology Moscow, Russia; 2007; 24-27 .
104. Scheuring RA, Mathers CH, Jones JA, Wear M. In-flight Musculoskeletal Injuries in the US Space Program: A Comprehensive Summary and Review of Trends. NASA Human Research Program Annual Investigators Meeting Bulletin Houston, TX 11-13, 2007.
105. Dewitt J, Jones JA, Velasquez L, et al. Shoulder Injuries and Potential Countermeasures during Weightlessness Training at the Neutral Buoyancy Laboratory. NASA Human Research Program Annual Investigators Meeting Bulletin Houston, TX 11-13, 2007.
106. Jones JA, Hoffman RB, Harvey CM, et al. Mechanism of Injury and Countermeasures for EVA Associated Upper Extremity Medical Issues: Vent Tube Evaluation.NASA Human Research Program Annual Investigators Meeting Bulletin Houston, TX 11-13, 2007.
107. Lee P, Braham S, Boucher M, et al. Haughton-Mars project: 10 years of scienceoperations and exploration systems development at amoon/Mars analog site on Devon Island, High Arctic. InProceedings of the 38th Lunar and Planetary Science Conference, League City, TX 2007; (pp. 2426-2427).
108. Scheuring RA, Duncan JM, Polk JD, et al. Apollo Medical Operations Project: An Overview. ASEM. 78(3): 292 [abstract 350] 2007 AsMA Annual meeting, New Orleans, LA.
109. Jones JA, Scheuring RA, Dervay J, Morin M, Gernhardt D, Gillis JD, Polk S, Johnston JM. Duncan. Apollo Medical Operations Project: Recommendations for the New Extravehicular Activity (EVA) Mobility Unit (EMU). ASEM 78(3): 293 [abstract 351] 2007 AsMA Annual meeting, New Orleans, LA.
110. Scheuring RA, Jones JA, Polk JD, et al. Apollo Medical Operations Project: Recommendations for Lunar Surface Operations. ASEM. 2007; 78(3): 293.
111. Scheuring RA, Jones JA, Polk JD, Gillis D, Duncan JM. Risk factors for injuries on the lunar surface: Recommendations for Lunar Surface Operations from the Apollo Medical Operations Project. ASEM. 2007; 78(3): 293.
112. Jones JA, Scheuring RA, Loerch L, et al. Apollo Medical Operations Project: Recommendations for Exploration Exercise, Food and Nutrition. ASEM. 2007; 78(3): 293.
113. Carpenter F, Scheuring RA, Bevin G, et al. Apollo Medical Operations Project: Behavioral Health and Performance Recommendations for Exploration Crews. ASEM. 2007; 78(3): 294.
114. Scheuring RA, Jones JA, Polk JD, et al. Apollo Medical Operations Project: Recommendations to Improve Environmental Impacts for the Exploration Spacecraft. ASEM. 2007; 78(3): 294.
115. Scheuring RA, Jones JA, Lee P, et al. Haughton Mars Project (HMP)/ NASA 2006 Lunar Medical Contingency Simulation: An Overview. ASEM. 2007; 78(3): 300.
116. Chappell SP, Scheuring RA, Jones JA, et al. Haughton Mars Project (HMP)/ NASA 2006 Lunar Medical Contingency Simulation: Equipment and Methods for Medical Evacuation of an Injured Crew member. ASEM. 2007; 78(3): 300.
117. Comtois J, Braham SP, Scheuring RA, et al. Haughton Mars Project (HMP)/NASA 2006 Lunar Medical Contingency Simulation: Communication Architecture. ASEM. 78(3): 300.
118. Jones JA, Scheuring RA, Martin D, et al. Haughton Mars Project (HMP)/ NASA 2006 Lunar Medical Contingency Simulation- Training Elements and Medical Diagnostics. ASEM. 2007; 78(3): 301.
119. Rafiq A, Scheuring RA, Jones JA, et al. Haughton Mars Project (HMP)/ NASA 2006 Lunar Medical Contingency Simulation-Biomedical Monitoring during a Medical Evacuation of an Injured Crewmember. ASEM. 2007; 78(3): 301.
120. Sargsyan AE, Jones JA, Hamilton DR, Dulchavsky S, Martin D, Duncan M. The Diagnostic Imaging in the Medical Support of Future Missions to the Moon. ASEM. 2007; 78(3): 301.
121. Jones JA, Hoffman RB, Harvey CM, Bowen CK, Hudy C, Gernhardt M. Mechanisms of Injury and Countermeasures for EVA Associated Upper Extremity Medical Issues: Extended Vent Tube Study. ASEM. 2007; 78(3): 301.
122. Rafiq A, Jones JA, Syed H, Boanca C, Le B, Scheuring RA, Merrell RC. Airway Management Skill Performances in Microgravity. ASEM. 2007; 78(3): 301.
123. Scheuring RA, Walton M, Davis-Street JE, et al. Recommendations from NASAs Operational Musculoskeletal Summit. ASEM. 2007; 78(3): 332.
124. Jones JA. “Possible Health Effects from Lunar Dust Exposure” NESC Lunar Dust Workshop, NASA Ames Research Center, Mountain View, CA, 2007.
125. Steve P. Chappell, Rick Scheuring, Jeff Jones, Pascal Lee, Jean-Marc Comtois, Ed Hodgson, Nick Wilkinson, Stephen Braham, Susan Torney, Pat Sullivan, Azhar Rafiq. Access Systems for Partial Gravity Exploration and Rescue: Results from Prototype Testing in an Analog Environment. 2007-01-3033 37th International Conference on Environmental Systems (ICES) Chicago, IL 9, 2007.
126. Rafiq A, Scheuring RA, Jones JA, Lee P, Comtois JM, Braham S, Sullivan P, Merrell R. Simulation deployment of Lunar Medical Contingency: Biomedical Monitoring Sensor Network for Medical Evacuation of an Injured Crewmember. Medicine Meets Virtual Reality Conference 16 Long Beach, CA 30-Feb1, 2008.
127. Jones JA, Scheuring R. Lunar Surface Operational Challenges. ASEM. 2008; 79(3): 245.
128. Jones JA, Toups L, Wagner S, Alexander D. Understanding Lunar Dust Hazard and Mitigation Strategies via Habitat Airlock/Suitlock and Other Engineering Approaches. ASEM. 2008; 79(3): 245.
129. Warmflash D, Barr YR, Leblanc AD, Jennings RT, Garcia Y, Jones JA. Post-Mission Sequelae of Long-Duration Space Flight. ASEM. 2008; 79(3): 245.
130. Scheuring RA, Van Baalen M, Zapp N, Jones JA, Shavers M, Vazquez ME. Management of Acute Radiation Exposures on the Lunar Surface for Exploration. ASEM. 2008; 79(3): 245.
131. Kuznetz L, Jones J, Lee P, Merrill RC, Rafiq A. Integrated Software Systems for Crew Management during Extravehicular Vehicle Activity in Planetary Terrain Exploration. ASEM. 2008; 79(3): 245.
132. Sargsyan AE, Hamilton DR, Jones JA, et al. The Quality of Spoken Discourse in Guided Medical Procedures on Orbit ASEM 79(3) p271 [275] Presented at AsMA Annual Meeting, Boston, MA 2008.
133. Jones JA, Gernhardt M, Jadwick J. Enabling Physiological and Biomechanical Science for Lunar Surface. ASEM. 2008; 79(3): 292.
134. Norcross JR, Stroud LC, Schaffner G, Glass BJ, Lee P, Jones JA, Gernhardt ML. The Effects of Terrain and Navigation on Human EVA Walkback Performance on the Moon. ASEM. 2008; 79(3): 292.
135. Scheuring RA, Mathers CH, Jones JA, Wear ML, Djojonegoro B. In-flight Musculoskeletal Injuries and Minor Trauma in the U.S. Space Program: A Comprehensive Summary of Occurrence and Injury Mechanism . ASEM. 2008; 79(3): 292.
136. Ulrich S, Rasheed A, Jones JA, Clement G. Adaptation of the Vestibulo-Ocular Reflexes to High G Accelerations and Pitching Motion. ASEM. 2008; 79(3): 292.
137. Kedar N. Prasad, Jeffrey A. Jones, William C. Cole, Rachael C. Casey, Gerald M. Haase. Steve R. Gonda, Nikolai Lisenko, Dmitri Popov,and Slava Maliev Multiple dietary and endogenously made antioxidants protect against a lethal dose of low LET radiation in sheep and rabbit models.USSOCOM: Chemical, Biological, Radiological & Nuclear Conference and Exhibition Tampa, FL 12/6-8/2005.
138. Lee P, Gernhardt M, Abercromby A, Jeffrey A. Jones, et al. Moon/Mars scienceand exploration in pressurized rovers: early lessons from analog studies at the Haughton-Mars Project site, Devon Island, high arctic. Lunar Planetary Science Conference. Woodlands, TX 3/23-27/09.
139. Ansari RR, Pollonini L, Rodriguez M, Jeffrey A, Jones MD. A new miniaturized wireless fiber-optic sensor fordistal finger-tip injuries in astronauts SPIE- BIOS 2009 conference. San Jose CA Session 2: Optic and Fiber Optic Blood Flow Measurements Conference 7186 – Proceedings of SPIE Volume 7186, Monday-Tuesday 26 – 27 uary 2009.
140. Whitson PA, Pietryzk RA, Sams CF, Jones JA, Nelman-Gonzales MA, Hudson EK. Renal Stone Risk During Space Flight: Assessment and Countermeasure Validation. NASA Human Research Program Investigator’s Workshop, League City, TX Feb 2, 2009. Abstract 1142.
141. Smith, SM, Zwart, SR, Heer, M, Ericson, K, Coburn, SP, Booth, SA, Jones, JA, Lupton, J. Nutritional Status Assessment on ISS. NASA Human Research Program Investigator’s Workshop, League City, TX Feb 2, 2009. Abstract 1008.
142. Gernhardt ML, Jones JA, Granderson BK, Somers J. Occupant Protection During Crew Exploration Vehicle Landing.Extravehicular Activity Session. NASA Human Research Program Investigator’s Workshop, LeagueCity, TX Feb 3, 2009.
143. Pieztryk RA, Whiston PA, Sams CF, Jones JA, Nelman-Gonzalez M, Hudson EK. Use of potassium citrate to reduce the risk of renal stone formation during spaceflight. ASEM. 2009; 80(3): 167.
144. Stepanek JP, Jones JA, Johnston SL, et al. Space Medicine Grand Rounds Abstract 129. ASEM. 2009; 80(3): 231.
145. Scheuring RA, Hamilton DR, Jones JA, Alexander D. Heart rhythm monitoring in the constellation lunar and launch/landing EVA suit: recommendations from an expert panel. ASEM. 2009; 80(3): 281.
146. Jones JA. Oxidative stress and antioxidants: Future directions for NASA. ASEM. 2009; 80(3): 284
147. Ciancio V, Sabelli S, Di-Giovan G, Oliveri P, Ciancio V, Bennett L, Jones JA. “HDPE’s cosmic radiation protection in argentine international flights” SAE Aerotech Conference Seattle, WA Nov 11, 2009.
148. Scheuring RA, Clark JB, Jones JA. “Return to flying duties following centrifuge and/or vibration Exposures”. Abstract 461. ASEM. 2010; 81(3): 333.
149. Ciancio VR, Sabelli S, Viancio V, Bennet L, Jones JA. “High density polyethylene cosmic radiation protection in Argentine international flights” ASEM. 2010; 81(3): 315.
150. Scheuring RA, Barratt MR, Parazynski S, Satcher RL, Marshburn TH, Jones JA “Medical Care delivery, training, exercise, research, in-fight medical conditions and future exploration missions” ASEM. 2010; 81(3): 329

BOOK CHAPTERS

1. Noon, G.P., Jones, J.A. Bleeding Associated with Cardiac Surgery. In: Decision Making In Surgery Of The Chest. Edited by Laurens R. Pickard. Philadelphia: W.B. Saunders Co., 1989.
2. Jones, JA, Lingeman JE, Steidle CP: The roles of extracorporeal shock wave lithotripsy and percutaneousNephrostolithotomy in the management of pyelocaliceal diverticula. Yearbook of Urology 1994, p64, Mosby, 1992.
3. Jones, JA, Mitchell ME, Rink RC: Improved results utilizing a modification in the YDL bladder neck repair.Yearbook of Urology 1994, Chapter 12, Mosby, pp89-92, 1994 Williams and Wilkins, May, 2002.
4. Jones, JA, et al. Ch. 3 Oxygen Generating Systems in Aviation and Space Flight In: Fundamentals of Aerospace Medicine, 3rd edition. Edited by Roy Dehart and Jeff Davis, Lippincott, Williams and Wilkins, May, 2002.
5. Jones, Jeffrey A., McGinnis, Patrick J., Hamilton, Douglas R., D’Aunno, Dominick, Simmons, Scott, Melton, Shannon, Armstrong Cheri Ch. 6.1 Telemedicine During Lunar-Mars Life Support Test Project Phase III. In: Volume 104 Isolation NASA Experiments in Closed-Environment Living. Edited by Lane, Helen, Sauer, Richard, and Feeback, Daniel. Advances in Astronautical Sciences, American Astronautical Society, Univelt Inc. San Diego, CA, 2002.
6. Mark S. F. Clarke, Ph.D., Jeff A. Jones, M.D., and Daniel L. Feeback, Ph.D. Syringe Loading: a method for assessing plasma membrane function as a reflection of the mechanically-induced membrane wound response. In: Cell Biology Handbook, Academic Press, 2005.
7.Jones, Jeffrey A.Ch. 28 Laser Ablation and Other Emerging Technologies In: Textbook of Bladder Cancer Eds. Seth Lerner, Cora Sternberg, Mark Schoenberg; Martin Dunitz, London, U.K. 2005.
8. Jones, JA, et al Radiation Disorders Ch. 23 pp475-520 In: Principles of Clinical Medicine for Space Flight. Eds. M. Barratt, S Pool, Springer, NYC, NY 2008.
9. Jones, JA, Whitson, P.Renal and Genitourinary Concerns Ch. 13 pp273-292 In: Principles of Clinical Medicine for Space Flight. Eds. M. Barratt, S Pool, Springer, NYC, NY 2008; 2nd edition- (in press).
10.Jeff Jones, Anne Pavy-Le Traon, Rupert Gerzer,John Byard, Larry Meeker, Randal Reinertson Ch. 12 Space Medical and Psychological Issues. In: Artificial Gravity Textbook ,editorsG. Clement, A. Buckley, Springer, July 6, 2007 ISBN-10: 0387707123.
11. Jones, Jeffrey A., Ciftcioglu, Neva. The Role of Nanobacteria/Calcifying Nanoparticles in Prostate Disease. Textbook of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Edited by Daniel Shoskes. Publisher is Humana Press and publishing date March 2008.
12. Jones, Jeffrey A. et al Urolithiasis and Genitourinary Systems Issues For Spaceflight n CP1049, RenalStone Disease 2, 2nd International Urolithiasis Symposium, edited Evan, AP, Lingeman, JE, McAteer, JA, and Williams, Jr., JC. American Institute of Physics, Melville, NY 2008; 978-0-7354-0577-6/08.
13. Grigoriev, AI, Potapov, AN, Jones, JA, Sullivan, T, Scheuring, R. Medical Support for Interplanetary Space FlightsIn: Space Biology and Medicine 2009.
14. Gernhardt, ML, Jones, JA, Scheuring, RA, Abercromby, AF, Tuxhorn, JA, Norcross, JR Chapter 14: Risk of Compromised EVA Performance and Crew Health due to Inadequate EVA Suit Systems. In: Human Health and Performance Risks of Space Exploration Missions. Editors: McPhee, JC and Charles, JB NASA SP-2009-3405 May 2009
15. Jones, JA, Charles, JB, et al. Chapter 7- Key Challenges in Human Health and Performance. In: Human Exploration of Mars Design Reference Architecture 5.0. Editor: Drake, BG. NASA SP-2009-566 NASA Center for Aerospace Information, Hanover, MD July 2009
16. Jones, JA, Karouia, F, Casey, R “Chapter 11- Ionizing Radiation as a Carcinogen”. In: Comprehensive Toxicology II, Volume 14- Carcinogenesis Elsevier Oxford, England June 2010 17. S. Marlene Grenon, Jeffrey A. Jones, Chad Ball, David Williams and Michael R. Barratt “Ch 3: Space Medicine for Exploration”Surgery in Extreme Environments(in press)
18. Jones, Jeffrey A, Jennings, Richard T., Baker, Ellen S. “Genitourinary Health Issues for Space Shuttle Missions” In: STS Biomedical Results (published July 2013) GPO 033-000-01363-9 ISBN :9780615866130
19. Popov, Dmitri, Jones, Jeffrey A., Maliev, Vladislav “Radiomimetics and Radioprotection” in “Ionizing Radiation Book 1 web-pub 2012.
20. Jones, J, Karouia, F, Cristae, O- . “Genitourinary Health Issues for Space Shuttle Missions” In: STS Biomedical Results (published July 2013) GPO 033-000-01363-9 ISBN.

MANUSCRIPT

1. Jones JA, Eden AR. Neuroanatomic studies on the vestibular efferent system of the pigeon using a double-label fluorescent tracer technique. (Read before the Dept of Otolaryngology Research Symposium, UTMB, Galveston, TX, 1981).
2. Nag A, Jones JA, Smith RG. Point mutation in cHa-ras oncogene in normal and abnormal cells. Lancet. 1989; 1(8632): 274-276. doi: 10.1016/S0140-6736(89)91280-4
3. Don S, Kopecky K, Filo RS, et al. Duplex Sonography in renal allografts causes of elevated resistive index. Radiology. 1989; 171(3): 709-712. doi: 10.1148/radiology.171.3.2655003
4. Jones JA, Ganesan GS, Cory D, Mitchell ME. Magnetic resonance imaging of a seminal vesical cyst and review of the imaging modalities. Indiana Medicine. 1991; 83: 322-326.
5. Ganesan GS, Mitchell ME, Cory D, Jones JA. Magnetic resonance imaging of a penile rhabdomyosarcoma. British J Radiology. 1992; 65(770): 175-178.
6. Jones JA, Mitchell ME. Improved results utilizing a modification of the Young-Dees- Ledbetter Bladder neck repair. Br J Urol. 1993; 71(5): 555-561. doi: 10.1111/j.1464-410X.1993.tb16024.x
7. Donohue JP, Foster R, Rowland RA, Bihrle R, Jones JA, Geier G. Nerve Sparing Retroperitoneal Lymphadenectomy with Preservation of Ejaculation. J Urol. 1990; 144(2 pt 1): 287-291. Web site. http://europepmc.org/abstract/med/2165181.
8. Donohue JP, Foster RS, Jones JA, Geier G. Nerve Sparing Preserves Sexual Function. Contemporary Urology. 1989: 41-46.
9. Hardacre J, Goulet RH, Einhorn LH, et al. Hepatic resection for metastatic testicular cancer. Ann Surg. 1990: 212(3): 290-310.
10. Jones JA, Lingeman JE, Steidle CP. ESWL vs PCNL in the management of pyelocaliceal diverticula. J Urol. 1990; 146(3): 724-727.
11. Lingeman JE, Jones JA. Treating Pyelocaliceal Diverticula. Contemporary Urology. 1991; 3: 35-41.
12. Jones JA, Foster R, Bihrle R. Hepatic mobilization: useful, expeditious maneuver. Contemporary Urology. 1992.
13. Jones JA, Lingeman JE, Steidle CP. The Roles of Extracorpoeal Shock Wave Lithotripsy and Percutaneous Nephrostolithotomy in the management of pyelocaliceal diverticula. J Urol. 1991; 146(3): 724-727. Web site. http://europepmc.org/abstract/med/1908528.
14. Jones JA, Mitchell ME, Rink RC. Improved results utilising a modification in the YDL bladder neck repair. Brit J Urol. 1993; 71: 555-561.
15. Vlahos CJ, Kriauciunas TD, Gleason PE, et al. Platelet-derived growth factor-induced proliferation of cells from human prostatic hyperplasia. J Cell Biochem. 1993; 52: 404-413.
16. Gleason PE, Jones JA, Regan JR, et al. Platelet Derived Growth Factor (PDGF), androgens inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol. 1993; 149(6): 1586-1592. Web site. http://europepmc.org/abstract/med/7684794.
17. Jones JA, Gleason PE, Regan JR, Salvas DR, Eble JN, Lamph WW, Vlahos CJ, Huang H, Hirsch KS. A model of inflammation as an etiologic agent in the development of prostatic hyperplasia: the roles of PDGF and androgens. (Society for Basic Urologic Research meeting and essay contest 5/92).
18. de Riese W, de Riese C, Ullbright T, et al. Flow-cytrometric and quantitative histologic parametersas prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ cell tumors. Int J Cancer. 1994; 57(5): 628-633. doi: 10.1002/ijc.2910570503
19. de Riese W, Walker E, de Riese C, et al. Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors (NSGCT). Urol Res. 1994; 22(4): 213-220. doi: 10.1007/BF00541895
20. Jones JA, Mitchell ME, Rink RC. Improved results utilizing a modification in the YDL bladder neck repair. Yearbook Urology. 1993; 71(5): 55-561. doi: 10.1111/j.1464-410X.1993.tb16024.x
21. Jones JA, Foster RF, Donohue JP. Results in management of extragonadal germ cell tumors. (in preparation)
22. Jones JA, Foster RF, Salvas D, Bennett R, Straub M, Donohue JP. Outcome in patients with testicular maldescent and germ cell neoplasia. (in preparation)
23. de Riese C, Crabtree WN, de Riese W, et al. Impact of the preparation technique on DNA content measured by image analysisin early stage human testis cancer. Int Urol Nephrol. 1995; 27(5): 603-613. doi: 10.1007/BF02564748
24. Cobos E, Yi-Kong K, Akhter S, Jones J. Use of recombinant factor VIIa for major elective surgery in a patient with factor VII deficiency, retroperitoneal fibrosis, and hydronephrosis. Clin Appl Thrombosis/Hemostasis. 1997; 3(1): 33-35. doi: 10.1177/107602969700300104
25. Jones JA, Salvas D, Straub MJ, et al. Characterization of prostate stromal cells to mediators of inflammation. (in preparation)
26. Jones JA, Ngyuen A, Straub MJ, Leidich RB, Wolf S. The use of oral DHEA in a patient with advanced prostate cancer: a case report. Urology. 1997; 50(5): 784-788. doi: 10.1177/107602969700300104
27. Avant L, Beck H, Hunt C, Jones J. Improvement results with a modified radical retropubic prostatectomy technique. Urology. 2000; 56: 658-662.
28. Stanford M, Jones JA. Space radiation concerns for a manned mission to mars. Acta Astronautica Vol. 1999; 45(1): 39-47. doi: 10.1016/S0094-5765(99)00055-7
29. Johnston S, Jones JA, Campbell M. The use of parabolic flights to evaluate new microgravity techniques in advanced cardiac life support, endoscopic surgery, ventilation support, crew medical restraint, defibrillation, crew medical officer training and physiological monitoring. NASA/JSC document 28318- KC-135 and Other Microgravity Simulations Summary Report of the Space and Life Sciences Directorate, Medical Sciences Division. Aug 1, 1998.
30. Jones JA, Johnston S, Campbell M, Billica R. Endoscopic Surgery and Telemedicine In Microgravity, Developing Contingency Procedures for Exploratory Class Space Flight. Urology. 1999; 53(5): 892-897. doi: 10.1016/S0090-4295(99)00024-2
31. Pedemonte CH, Yang TC, Riggs PK, Jones JA. Effects of Heavy Ion Radiation on Epithelial Cell Membranes . Institute for Space Systems Operations, University of Houston, 1997-98 Annual Report Houston: ISSO Print and Electronic Publications, 1998 pp. 40-44.
32. Jones JA, Hart S, Baskin D, et al. Human and behavioral factors contributing to spinal-based neurological cockpit injuries in pilots of high performance aircraft: recommendations for management and prevention. Military Medicine. 2000; 165: 6-12.
33. Pienta KJ, Fisher EI, Eisenberger MA, et al. Phase II Trial of Estramustine and Etoposide in Hormone Refractory Prostate Cancer: A Southwest Oncology Group Trial. Prostate. 2001; 46(4): 257-261. Website. https://deepblue.lib.umich.edu/bitstream/handle/2027.42/34757/1031_ftp.pdf?sequence=1&isAllowed=y.
34. Hussain MHA, Glass TR, Forman J, et al. Combination Cisplatin, 5-Fluorouracil and Radiation Therapy in Locally Advanced Unresectable or Medically Unfit Bladder Cancer Patients. A Southwest Oncology Group Study. J Urology. 2001; 165(1): 56-61. doi: 10.1097/00005392-200101000-00014
35. Rawat N, Connor CW, Jones JA, Kozlovskaya I, Sullivan P. The correlation between aerobic fitness and motion sickness susceptibility. Aviat Space Environ Med. 2002; 73(3): 216-218.
36. Jones JA, Riggs PK, Yang T, Pedemonte CH, Clarke M, Feedback D, W. Au. Ionizing Radiation-Induced Bioeffects in Space and Strategies to Reduce Cellular Injury and Carcinogenesis. Aviat Space Environ Med. 2007; 78(4): A67-A78. Web site. http://www.ingentaconnect.com/content/asma/asem.
37. Cockell C, Lee P, Hidalgo L, Jones J, Stokes MD, Schuerger A. Microbiology and Vegetation of Micro-Oases and Polar Desert, Haughton Impact Crater, Devon Island, Nunavut, Canada. Arctic, Antarctic and Alpine Research. 2001; 33(3): 306-318. doi: 10.2307/1552238
38. Jones JA, Barratt M, Effenhauser R, Cockell C, Lee P. Medical Issues for a Human Mission to Mars and Martian Surface Expeditions. J Br Interplanet Soc. 2004; 57(3/4): 144-160.
39. Larios-Sanz M, Kourentzi K, Warmflash D, et al. 16S rRNA Beacons for Bacterial Monitoring in Craft and Habitat Modules in Human Space Missions. Aviat Space Environ Med. 2007; 78(4:) A43-A47. Web site. http://www.ingentaconnect.com/content/asma/asem.
40. Warmflash D, Larios-Sanz M, Jones JA, Fox GE, Mckay DA. Assessing the biohazard potential of putative martian organisms for exploration class human space missions. Aviat Space Environ Med. 2007; 78(4): A79-A88. Web site. http://www.ingentaconnect.com/content/asma/asem.
41. Jones JA, Wells K, Thomas G, Effenhauser R. Life and Medical Support System Terrestrial Analog Utilization to Prepare for Human Solar System in Exploration Engineering, Construction, and Operations in Challenging Environments, Eds. R. B. Malla, A. Maji, ASCE Reston, VA January, 2004, 93.
42. Petrylak DP, Tangen CM, Hussain MHA, et al. Docetaxel and Estramustine vs. Mitoxantrone and prednisone: Results of Southwest Oncology Group Intergroup Protocol 99-16. New Engl J Med. 2004; 351(15): 1513-1520. doi: 10.1056/NEJMoa041318
43. Viegas S, Jones JA, Williams D, Clark J, Strauss S. “Physical Demands and Injuries to the Upper Extremity Associated with the Space Program”. J Hand Surg Am. 2004; 29(3): 359-366. doi: 10.1016/j.jhsa.2004.01.015
44. Matuszczak Y, Farid M, Jones J, Landsdowne S, Taylor AA, Michael B. Reid N-Acetylcysteine Inhibits Muscle Fatigue and Glutathione Oxidation During Handgrip Exercise. Muscle and Nerve. 2005; 32(5): 633-638.
45. Whitson P, Bergh K, Maender C, Pietrzyk R, Jones J, Sams C. Renal Stone Risk During Spaceflight: Assessment and Countermeasure Validation. IEEE Annual Meeting Bulletin 2004.
46. Rafiq A, Broderick TJ, Williams DR, Doarn CR, Jones JA, Merrell RC. Assessment of surgical Skills in parabolic gravity. Aviation, Space Environ Med. 2005; 76(4): 385-391.
47. Kirkpatrick AW, Campbell MR, Jones JA, et al. Extraterrestrial Hemorrhage Control: Terrestrial Developments in Technique, Technology, and Philosophy with Applicability to Traumatic Hemorrhage Control during Long Duration Spaceflight. J Am Coll Surg. 2005; 200(1): 64-76. doi: 10.1016/j.jamcollsurg.2004.08.028
48. Sargasyan AE, Hamilton DR, Jones JA, et al. FAST at MACH 20: Clinical Ultrasound aboard the International Space Station. J Trauma. 2005; 58(1): 35-39. Web site. http://journals.lww.com/jtrauma/pages/articleviewer.aspx?year=2005&issue=01000&article=00006&type=abstract.
49. Jones JA, Jennings R, Pietryzk R, Ciftcioglu N, Stepaniak P. Genitourinary Issues during spaceflight : a review. Int J Impot Res. 2005; 17 Suppl 1: S64-S67. doi: 10.1038/sj.ijir.3901431
50. Miller JH, Wosik J, McKay D, et al. Martian Soil Biosensors Based on Dielectric Spectroscopy. Institute for Space Systems Operations, Y2005 Annual Report. University of Houston/ Johnson Space Center. 33-38.
51. Petrylak DP, Ankerst DP, Jiang CS, et al. Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16. J Natl Cancer Inst. 2006; 98(8): 516-521. doi: 10.1093/jnci/djj129
52. Jones, Jeffrey A, Polk JD, Scheuring R. Exploration Medical Support System- The Future of Human Spaceflight Health. Flightlines: Society of USAF Flight Surgeons Bulletin. 2006; 21(7): 17-18.
53. Maliev V, Popov D, Casey RC, Jones JA. Mechanisms of action for an anti-radiation vaccine in reducing the biological impact of high-dose and dose-rate low-LET radiation exposure. Radians Biol Radioecol. 2007; 47(3): 286-291. Web site. http://europepmc.org/abstract/med/17867496.
54. Maliev V, Popov D, Jones JA, Casey RC. Mechanism of action for anti-radiation vaccine in reducing the biological impact of high-dose irradiation. Adv Space Res. 2007; 40(4): 586-590. doi: 10.1016/j.asr.2007.03.098
55. Djojonegoro B, Jones JA. Kidney Stones Longitudinal Study of Astronaut Health Newsletter 2006; 14(2): 1-4.
56. Barr YR, Bacal K, Jones JA, Hamilton DR. The risk and management of breast cancer for space exploration. ASEM. 2007; 78(4 suppl): A26-A37.
57. Stepaniak, Philip C Ramchandani, Suneil R, Jones Jeffrey A. Acute Urinary Retention in Space: Presentation and Management. ASEM. 78(4 suppl.) Section II2007 A5-A8.
58. Jones, Jeffrey A, McCarten, Michael, Manuel, Keith, Djojonegoro, Baby, Murray, Jocelyn, Feiversen, Al, Wear, Mary. Understanding Cataract Risk in Aerospace Flight Crew And Review of Mechanisms of Cataract Formation. ASEM. 2007; 78(4 suppl): A56-A66.
59. Hamilton DR, Scheuring R, Jones, JA. Right Lower Quadrant Abdominal Pain in a Female Crewmember on the International Space Station. ASEM. 2007; 78(4 suppl): A89-A98. Web site. http://www.ingentaconnect.com/content/asma/asem/2007/00000078/A00104s1/art00013.
60. Kirkpatrick AW, Jones JA, Sargsyan A, Hamilton D, Beck G. Evaluating Trauma Sonography for Operational Use in the Microgravity Environment. ASEM. 2007; 78(4suppl): A38-A42.
61. Pietryzk RA, Jones JA, Sams CF, Whitson PA. Characteristics of Renal Stone Formation Among US Astronauts. ASEM. 2007; 78(4 suppl): A9-A13.
62. Jones JA, Kirkpatrick A, Hamilton DR, et al. Percutaneous Bladder Catheterization in Microgravity. Can J Urol. 2007; 14(2): 3493-3498. Web site. http://www.canjurol.com/abstract.php?ArticleID=&version=1.0&PMID=17466154.
63. Crucian B, Lee P, Stowe R, et al. Field immune assessment during simulated planetary exploration on Devon Island, High Arctic. BMC Immunology. 2007; 8: 7. doi: 10.1186/1471-2172-8-7 http://bmcimmunol.biomedcentral.com/articles/10.1186/1471-2172-8-7 64. Chappell S, Scheuring R, Jones J, et al. Rafiq Access Systems for Partial Gravity Exploration & Rescue: Results from Prototype Testing in an Analog Environment. ICES 2007.
65. Scheuring R, Jones J, Polk JD, Gillis D, Schmid J, Duncan M, Davis J, Novak J. The Apollo Medical Operations Project: Recommendations to Improve Crew Health and Performance for Future Exploration Missions and Lunar Surface Operations. NASA/TM 2007-214755, Sept 2007.
66. Cucinotta F, Manuel K, Jones, J et al. Space radiation and cataracts in astronauts. Radiat Res. 2001; 156(5 Pt 1): 460-466. Web site. http://www.rrjournal.org/doi/abs/10.1667/0033-7587(2001)156[0460:SRACIA]2.0.CO%3B2. 67. Cucinotta F, Manuel K, Jones JA, et al Erratum Radiat Res 2001; 156: 811.
68. Scheuring RA, Mathers CH, Jones JA, et al. In-flight musculoskeletal injuriesand minor trauma in the U.S. space program: a comprehensive summary of occurrence and injury mechanism. ASEM. 2009; 80(2): 117-124.
69. Scheuring RA, Conkin J, Jones J, Gernhart M. Risk Assessment of Physiological Effects of Atmospheric Composition and Pressure in Constellation VehiclesActa AstronauticaVol 63, Issues 7-10, October-November 2008, p 727-739 (From Dream to Reality: Living, Working and Creating for Humans in Space – A selection of papers presented at the 16th IAA Humans in Space Symposium, Beijing, China, 2007)
70. Ciftcioglu N, Vejdani K, Lee O, et al. Association between Randall’s plaque and calcifying nanoparticles. Int J Nanomedicine. 2008; 3(1): 105-115.
71. Jones, Jeffrey A, Ciftcioglu, Neva, Schmid, Josef F., Barr, Yael R., and Griffith, Donald. Calcifying Nanoparticles (Nanobacteria): An Additional Potential Factor for Urolithiasis in Space Flight Crews: A Case Report. Urology. 2008.
72. Jones JA, Hoffman RB, Harvey CM, Bowen CK, Hudy CE, Strauss S, Gernhardt ML. Mechanisms of Injury and Countermeasures for EVA Associated Upper Extremity Medical Issues: Extended Vent Tube Study Acta AstronauticaVol 63, Issues 7-10 October-November 2008, p 763-768 (From Dream to Reality: Living, Working and Creating for Humans in Space – A selection of papers presented at the 16th IAA Humans in Space Symposium, Beijing, China, 2007).
73. Harvey C, Jones JA, Whitmore M, Gernhart M. Wearability Comfort and Field of View Findings from the Integrated Launch Suit Test NASA TP-2007-214754.
74. Dewitt J, Jones JA, Velasquez L, et al. Evaluation of the Hard Upper Torso Shoulder Harness NASA/JSC TP-2007-214751.
75. Scheuring RA, Jones JA, Polk JD. Human spaceflight health systems for the Constellation Project. Aviat Space Environ Med. 2007; 78(12): 1179-1180.
76. Jones, Jeffrey A, Roden, Sean, Schmid, Josef, Hart, Stephan, Powers, Ed, Taddeo, Terry, Polk, JD, Hamilton, Doug, Duncan, J Michael. International Space Station Medical Operations. Aviat Space Environ Med. 2008; 79(6): 646-647.
77. Ad hoc Committee of SMA and SNFS: Baisden, Beven, Campbell, Charles, Dervay, Foster, Gray, Hamilton, Holland, Jennings, Johnston, Jones, Kerwin, Locke, Polk, Scarpa, Sipes, Stepanek, Webb. Human Health and Performance for Long-Duration Spaceflight. Aviat Space Environ Med. 2008; 79(6): 629-635.
78. Jones JA, Barr Y, Cherien S, Stocco A. Medullary Sponge Kidney and Urinary Calculi: Aeromedical Concerns. Aviat Space Environ Med. 2008; 79: 707-711.
79. Jones JA, Sargsyan A, Barr Y, et al. Diagnostic Ultrasound at MACH 20: Retroperitoneal and Pelvic Imaging in Space. J Ultrasound Med & Biol. 2009; 1-9.
80. Ansari RA, Jones JA, Pollonini L, Rodriguez M, Opperman R, Hochstein. A Non-Invasive Miniaturized-Wireless Laser-Doppler Fiber-Optic Sensor for Understanding Distal Fingertip Injuries in Astronauts. SPIE 7186-08 ICES 2009.
81. Ansari RA, Jones JA, Hochstein J, Opperman R, Waldie J, Natapoff A. Anthropometric and Blood Flow Characteristics Leading to EVA Hand Injury 21 Sept 2009 http://vcc-sae.org/abstracts/3602-anthropometric-and-blood-flow-characteristics-leading-eva-hand-injury
82. Thompson S, Holden K, Ebert D, Root P, Adelstein B, Jones J. Short Duration Bioastronautics Investigation (SDBI) 1904: Final Report for STS-119 and STS-128. Nov 2009.
83. Epperly, MW, Wang, H, Jones, JA, Dixon T, Montesinos CA, Greenberger JS. Antioxidant Chemoprevention Diet Ameliorates Late Effects of total Body Irradiation and Supplements Radiation Protection by Mn-SOD Liposome Administration. Radiat Res. 82, 2011; 175(6): 759-765.
84. Jones JA, Epperly M, Law J, et al. Space Radiation Hazards and Strategies for Astronaut/Cosmonaut Protection Medical Radiology & Rad Safety 4 July-Aug 2013.
85. Leblanc A, Matsumoto T, Jones J, et al. Bisphosphonates as a supplement to exercise to protect bone during long-duration spaceflight. Osteoporos Int. 2013; 24(7): 2105-2114. doi: 10.1007/s00198-012-2243-z
86. Ball Chad G, Kirkpatrick AW, Williams DR, et al. Prophylactic surgery prior to extended-duration space flight: Is the benefit worth the risk? Can J Surg. 2012; 55(2): 125-129. doi: 10.1503/cjs.024610
87. Jeffrey T. Somers, Richard Scheuring, Bradley Granderson, Jeffrey Jones, Nathaniel Newby, Michael Gernhardt Defining NASA Risk Guidelines for Capsule-based Spacecraft Occupant Injuries Resulting from Launch, Abort and LandingNASA/TM-2014-217383